The Aflac Cancer Center BMT team has the skill to perform both allogeneic and autologous transplants.
What does this data mean?
This graph shows the total number of BMTs performed each year by type of transplant. With autologous transplants, the patient is the donor. With allogeneic transplants, someone other than the patient is the donor. Blood stem cells may be taken from the donor’s blood, bone marrow or an umbilical cord blood unit.
Why is this important?
The type of BMT a child gets is based on his disease and who is the best donor. Our transplant program is uniquely designed to care all of a child’s needs with doctors who are skilled in both allogeneic and autologous transplants.
How does the Aflac Cancer Center help ensure we are providing high-quality care?
- A large, 50+ person faculty includes pediatric-trained oncologists (cancer doctors), hematologists (blood disorder doctors), BMT doctors and researchers.
- Family support team, including child life specialists who educate children and families about what to expect before, during and after a BMT
- The inpatient unit has 10 specially designed, high efficiency particulate air (HEPA)-filtered rooms, as well as a playroom just for BMT patients.
- The HEPA-filtered BMT outpatient suite has five private rooms for infusions, treatments and exams.
- We are accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), making the Aflac Cancer Center the only FACT-accredited pediatric BMT center in Georgia.
- Our patients have access to approximately 250 clinical trials, affording the access to some of the most novel treatment options in the country